Vimarsana
Biggest News Aggregation in the World

Bridging Studies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bridging Studies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bridging Studies Today - Breaking & Trending Today

Transcripts For MSNBC MSNBC Live With Katy Tur - Vimarsana News

Transcripts For MSNBC MSNBC Live With Katy Tur

motive. >> i know that many have received a number of calls about, is this a hate crime. we're still early in this investigation, so we cannot make that determination at this moment. again, we are very early in this investigation. even though we have made an arrest, there is still a lot more work to be done. >> he made indicators that he has some issues, potentially sexual addiction, and may have frequented some of these places in the past. >> he claims that these -- as the chief said, it's still early, but he does claim it was not racially motivated. he apparently has an issue, what...

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates - Vimarsana News

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates - Vimarsana News

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates - Vimarsana News

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates - Vimarsana News

Antengene Announces 2021 Full Year Financial Results and Provides Corporate Updates

- XPOVIO® (selinexor) approvals received in Mainland China, Australia, South Korea and Singapore, expect Hong Kong and Taiwan in remainder of 2022. - 2021 Revenue of RMB28.8 million, Named Patient Program paving way for strong commercial launch in 2022. - Broad and deep clinical program of 18 studies, including 5 registrational studies, ongoing across multiple regions. - Strong cash,...